February 11, 2010 09:38 ET

Wall Street News Alert: Breaking News: Caleco Pharma Corp. -- February 11, 2010

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL--(Marketwire - February 11, 2010) - Wall Street News Alerts' "stocks to watch" this morning are: Caleco Pharma Corp. (OTCBB: CAEH), Baidu, Inc. (NASDAQ: BIDU), Microsoft Corp (NASDAQ: MSFT) and Pfizer Inc. (NYSE: PFE).

Yesterday after the markets closed, Caleco Pharma Corp. (OTCBB: CAEH) issued a press release announcing that it has entered into a share purchase agreement (the "Share Purchase Agreement") with Natac Biotech S.L. ("Natac"), a Spanish biotechnology corporation engaged in the research and development of health related products, and the principal stockholders of Natac (the "Principal Stockholders"). Under the terms of the Share Purchase Agreement, the Company has agreed to acquire eighteen percent (18%) of the share capital of Natac from the Principal Stockholders (the "Natac Shares"). In consideration of the Natac Shares, the Company has agreed to issue an aggregate of 4,300,000 shares of its common stock to the Principal Stockholders.

The closing of the Share Purchase Agreement is expected to occur on or before March 19, 2010 and is subject to a number of customary conditions, including:

(a) the closing of a research and licensing agreement whereby the Company will acquire an exclusive license to certain probiotic strains for the countries located in North and South America;

(b) the closing of an exclusive licensing agreement whereby the Company will acquire an exclusive license to certain health related products for the countries located in North and South America; and

(c) the closing of a lab facilities and services agreement whereby Natac shall provide certain services and laboratory access to the Company.

Following closing of the Share Purchase Agreement, Natac has agreed to appoint a nominee of the Company to the Board of Directors of Natac. In addition, the Company has also agreed to appoint a nominee of Natac to its Board of Directors.

Natac is a start-up Spanish biotechnology corporation engaged in the research and development of health related products. Natac has recently formed a strategic alliance with the Universidad Autónoma de Madrid in order to enhance its research and development of health related products. The strategic alliance will be carried out through a spin off into a separate Spanish corporation called "Natac Research S.L." of which Natac owns forty-seven percent (47%) of the share capital, the University owns six percent (6%) of the share capital and various professors and lecturers of the University own the balance of the issued share capital. Through Natac Research S.L., Natac will have access to the over 1,200 square meters of laboratory facilities and a pilot plant with advanced scientific equipment in order to conduct its research and development of various health related products.

The stock closed yesterday at Twenty Four cents a share.

For an in-depth profile of Caleco Pharma, visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=CAEH_021010.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit www.WallStreetNewsAlert.com and you can also follow Wall Street News Alerts on Twitter at http://twitter.com/wsna

Baidu, Inc. (NASDAQ: BIDU) up 10.8% on 5.6 million shares traded. Baidu, Inc. is the leading Chinese language Internet search provider.

Microsoft Corp (NASDAQ: MSFT) down 0.07% on 47.9 million shares traded. Microsoft is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.

Pfizer Inc. (NYSE: PFE) down 0.7% on 59.9 million shares traded. At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life.

Market Commentary:

Crude oil rose 84 cents to $74.59 per barrel on the New York Mercantile Exchange.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Caleco Pharma Corp. (OTCBB: CAEH), WSCF has been compensated Forty Thousand Dollars, by a third party who is non-affiliated and may hold a significant position in the stock. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.